T1	Participants 105 123	stage III melanoma
T2	Participants 250 291	stage III (regional lymph nodes) melanoma
T3	Participants 320 362	patients without any detectable metastases
T4	Participants 547 605	Eighty-eight patients determined as eligible for treatment
T5	Participants 924 962	group with only one invaded lymph node
T6	Participants 1282 1368	group with more than one invaded lymph node whatever the number of invaded lymph nodes
T7	Participants 1812 1820	melanoma
